{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:19:10Z","timestamp":1787494750937,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T00:00:00Z","timestamp":1625270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Coronary artery disease (CAD) is a dilemma and a serious cause of morbidity and mortality worldwide. Since CAD has been seen in people without the conventional risk factors like smoking, diabetes, and hypertension, the infectious theory being a risk factor has arisen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (HP) infection is the most common infection affecting the vast majority of the population worldwide. HP grows in the gastrointestinal tract (GIT) and responsible for chronic gastritis, peptic ulcer, gastric adenocarcinoma, and gastric lymphoma. A review of medical literature mainly PubMed has revealed several studies reporting that HP pathogenesis extends beyond the GIT to be a predisposing factor for atherosclerosis, dyslipidemia, thrombosis, and CAD. However, it remains a controversial issue that warrants extensive research.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This article gives insight into the diversity of opinions, evidence, and theories regarding the association between HP infection and CAD. The idea that CAD may be managed with antibiotics in certain patients seems to be creative and inspiring. More research is mandatory to either verify or reject this proposed correlation with strong scientific evidence and also to demonstrate the implications of the results on CAD management and outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-021-00185-2","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T09:02:29Z","timestamp":1625302949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?"],"prefix":"10.1186","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-5895","authenticated-orcid":false,"given":"Mohamed","family":"Riad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,3]]},"reference":[{"issue":"12","key":"185_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/CIRCRESAHA.116.304521","volume":"116","author":"M Hayashi","year":"2015","unstructured":"Hayashi M, Shimizu W, Albert CM (2015) The spectrum of epidemiology underlying sudden cardiac death. Circ Res 116(12):1887\u20131906. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.304521 PMID: 26044246; PMCID: PMC4929621","journal-title":"Circ Res"},{"issue":"9859","key":"185_CR2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(12)61728-0","journal-title":"Lancet"},{"issue":"5","key":"185_CR3","doi-asserted-by":"publisher","first-page":"610","DOI":"10.4244\/eijv5i5a98","volume":"5","author":"IM Lang","year":"2009","unstructured":"Lang IM, Forman SA, Maggioni AP, Ruzyllo W, Renkin J, Vozzi C, Steg PG, Hernandez-Garcia JM, Zmudka K, Jimenez-Navarro M, Sopko G, Lamas G, Hochman J (2009) Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT). EuroIntervention. 5(5):610\u2013618. https:\/\/doi.org\/10.4244\/eijv5i5a98","journal-title":"EuroIntervention."},{"issue":"1","key":"185_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1592\/phco.20.1.52.34659","volume":"20","author":"WB Wierzbicki","year":"2000","unstructured":"Wierzbicki WB, Hagmeyer KO (2000) Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease. Pharmacotherapy. 20(1):52\u201363. https:\/\/doi.org\/10.1592\/phco.20.1.52.34659 PMID: 10641975","journal-title":"Pharmacotherapy."},{"issue":"25","key":"185_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3238\/arztebl.2018.0429","volume":"115","author":"W Fischbach","year":"2018","unstructured":"Fischbach W, Malfertheiner P (2018) Helicobacter Pylori infection: when to eradicate, how to diagnose and treat. Dtsch Arztebl Int 115(25):429\u2013436. https:\/\/doi.org\/10.3238\/arztebl.2018.0429 Published online 2018 Jun 22. Continuing Medical Education","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"185_CR6","first-page":"112","volume":"10","author":"S Diaconu","year":"2017","unstructured":"Diaconu S, Predescu A, Moldoveanu A, Pop CS, Fierbin\u021beanu-Braticevici C (2017) Helicobacter pylori infection: old and new. J Med Life 10(2):112\u2013117 PMID: 28616085; PMCID: PMC5467250","journal-title":"J Med Life"},{"issue":"7","key":"185_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1751-2980.2012.00599.x","volume":"13","author":"HJ Tan","year":"2012","unstructured":"Tan HJ, Goh KL (2012) Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J Dig Dis 13(7):342\u2013349. https:\/\/doi.org\/10.1111\/j.1751-2980.2012.00599.x PMID: 22713083","journal-title":"J Dig Dis"},{"issue":"Suppl 1","key":"185_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1523-5378.2011.00883.x","volume":"16","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A (2011) Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 16(Suppl 1):65\u201369. https:\/\/doi.org\/10.1111\/j.1523-5378.2011.00883.x PMID: 21896088","journal-title":"Helicobacter."},{"issue":"36","key":"185_CR9","doi-asserted-by":"publisher","first-page":"12818","DOI":"10.3748\/wjg.v20.i36.12818","volume":"20","author":"G Campuzano-Maya","year":"2014","unstructured":"Campuzano-Maya G (2014) Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol 20(36):12818\u201312838. https:\/\/doi.org\/10.3748\/wjg.v20.i36.12818 PMID: 25278680; PMCID: PMC4177465","journal-title":"World J Gastroenterol"},{"issue":"3","key":"185_CR10","first-page":"193","volume":"53","author":"E Vizzardi","year":"2011","unstructured":"Vizzardi E, Bonadei I, Piovanelli B, Quinzani F, Ricci C, Lanzini A, Dei CL (2011) Helicobacter pylori and ischemic heart disease. Panminerva Med 53(3):193\u2013202 PMID: 21775946","journal-title":"Panminerva Med"},{"issue":"1","key":"185_CR11","first-page":"41","volume":"12","author":"MS Rezaee-Zavareh","year":"2016","unstructured":"Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B (2016) Infectious and coronary artery disease. ARYA Atheroscler 12(1):41\u201349 PMID: 27114736; PMCID: PMC4834180","journal-title":"ARYA Atheroscler"},{"issue":"4","key":"185_CR12","first-page":"233","volume":"1","author":"A Ismail","year":"1999","unstructured":"Ismail A, Khosravi H, Olson H (1999) The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Dis 1(4):233\u2013240 PMID: 11720630","journal-title":"Heart Dis"},{"issue":"1","key":"185_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4330\/wjc.v7.i1.19","volume":"7","author":"V Sharma","year":"2015","unstructured":"Sharma V, Aggarwal A (2015) Helicobacter pylori: does it add to risk of coronary artery disease. World J Cardiol 7(1):19\u201325. https:\/\/doi.org\/10.4330\/wjc.v7.i1.19 PMID: 25632315; PMCID: PMC4306202","journal-title":"World J Cardiol"},{"issue":"1 Suppl 1","key":"185_CR14","first-page":"3","volume":"52","author":"M Kowalski","year":"2001","unstructured":"Kowalski M (2001) Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52(1 Suppl 1):3\u201331","journal-title":"J Physiol Pharmacol"},{"issue":"10","key":"185_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/00365520310005622","volume":"38","author":"MF Byrne","year":"2003","unstructured":"Byrne MF, Murphy JF, Corcoran PA, Atherton JC, Sheehan KM, Cox D, Murray FE, Fitzgerald DJ (2003) Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol 38(10):1023\u20131030. https:\/\/doi.org\/10.1080\/00365520310005622 PMID: 14621275","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"185_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<237::AID-PATH541>3.0.CO;2-N","volume":"190","author":"OJ de Boer","year":"2000","unstructured":"de Boer OJ, van der Wal AC, Becker AE (2000) Atherosclerosis, inflammation, and infection. J Pathol 190(3):237\u2013243. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(200002)190:3<237::AID-PATH541>3.0.CO;2-N PMID: 10685058","journal-title":"J Pathol"},{"issue":"27","key":"185_CR17","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.3748\/wjg.v13.i27.3742","volume":"13","author":"FH Guo","year":"2007","unstructured":"Guo FH, Yan XM, Fan CX, Zhao F, Hu Y, Xiao D, Zeng X, Zhang MJ, He LH, Meng FL, Zhang JZ (2007) Cross-reactivity of anti-H pylori antibodies with membrane antigens of human erythrocytes. World J Gastroenterol 13(27):3742\u20133746. https:\/\/doi.org\/10.3748\/wjg.v13.i27.3742 PMID: 17659737; PMCID: PMC4250649","journal-title":"World J Gastroenterol"},{"issue":"3","key":"185_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","volume":"164","author":"M F\u00e9l\u00e9tou","year":"2011","unstructured":"F\u00e9l\u00e9tou M, Huang Y, Vanhoutte PM (2011) Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164(3):894\u2013912. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01276.x PMID: 21323907; PMCID: PMC3195913","journal-title":"Br J Pharmacol"},{"issue":"1","key":"185_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/0975-3583.91597","volume":"3","author":"Y Rasmi","year":"2012","unstructured":"Rasmi Y, Seyyed-Mohammadzad MH (2012) Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X. J Cardiovasc Dis Res 3(1):19\u201321. https:\/\/doi.org\/10.4103\/0975-3583.91597 PMID: 22346140; PMCID: PMC3271675","journal-title":"J Cardiovasc Dis Res"},{"issue":"2","key":"185_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1161\/01.cir.96.2.396","volume":"96","author":"F Mach","year":"1997","unstructured":"Mach F, Sch\u00f6nbeck U, Bonnefoy JY, Pober JS, Libby P (1997) Activation of monocyte\/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 96(2):396\u2013399. https:\/\/doi.org\/10.1161\/01.cir.96.2.396 PMID: 9244201","journal-title":"Circulation."},{"issue":"3","key":"185_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.res.81.3.448","volume":"81","author":"U Sch\u00f6nbeck","year":"1997","unstructured":"Sch\u00f6nbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res 81(3):448\u2013454. https:\/\/doi.org\/10.1161\/01.res.81.3.448 PMID: 9285647","journal-title":"Circ Res"},{"issue":"4","key":"185_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1161\/01.cir.100.4.e20","volume":"100","author":"SE Epstein","year":"1999","unstructured":"Epstein SE, Zhou YF, Zhu J (1999) Infection and atherosclerosis: emerging mechanistic paradigms. Circulation. 100(4):e20\u2013e28. https:\/\/doi.org\/10.1161\/01.cir.100.4.e20 PMID: 10421626","journal-title":"Circulation."},{"issue":"Suppl 1","key":"185_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1523-5378.2003.00166.x","volume":"8","author":"D Lamarque","year":"2003","unstructured":"Lamarque D, Peek RM Jr (2003) Pathogenesis of Helicobacter pylori infection. Helicobacter 8(Suppl 1):21\u201330. https:\/\/doi.org\/10.1046\/j.1523-5378.2003.00166.x PMID: 14617214","journal-title":"Helicobacter"},{"issue":"1","key":"185_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2004.09.010","volume":"179","author":"H Shmuely","year":"2005","unstructured":"Shmuely H, Passaro DJ, Vaturi M, Sagie A, Pitlik S, Samra Z, Niv Y, Koren R, Harell D, Yahav J (2005) Association of CagA+ Helicobacter pylori infection with aortic atheroma. Atherosclerosis. 179(1):127\u2013132. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.09.010 Epub 2004 Dec 29. PMID: 15721018","journal-title":"Atherosclerosis."},{"issue":"2","key":"185_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ijid.2004.10.008","volume":"10","author":"M Kaplan","year":"2006","unstructured":"Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, Gercekoglu H, Demirtas MM (2006) Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 10(2):116\u2013123. https:\/\/doi.org\/10.1016\/j.ijid.2004.10.008","journal-title":"Int J Infect Dis"},{"issue":"3","key":"185_CR26","first-page":"213","volume":"38","author":"A Pinar","year":"2004","unstructured":"Pinar A, O\u00e7 M, Aky\u00f6n Y, Farsak B, Ko\u00e7yildirim E, Us D, Zorlutuna Y, Tokg\u00f6zo\u011flu L, B\u00f6ke E (2004) Aterosklerozda Chlamydophila pneumoniae, Helicobacter pylori ve cytomegalovirus varli\u011finin molek\u00fcler ve serolojik y\u00f6ntemlerle ara\u015ftirilmasi [The presence of Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus in human atherosclerosis detected by molecular and serological methods]. Mikrobiyol Bul 38(3):213\u2013222 Turkish. PMID: 15490840","journal-title":"Mikrobiyol Bul"},{"issue":"7","key":"185_CR27","first-page":"1068","volume":"26","author":"AK Adiloglu","year":"2005","unstructured":"Adiloglu AK, Ocal A, Can R, Duver H, Yavuz T, Aridogan BC (2005) Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation. Saudi Med J 26(7):1068\u20131074 PMID: 16047055","journal-title":"Saudi Med J"},{"issue":"1","key":"185_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12944-019-1034-3","volume":"18","author":"P Narindrarangkura","year":"2019","unstructured":"Narindrarangkura P, Bosl W, Rangsin R, Hatthachote P (2019) Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand. Lipids Health Dis 18(1):90. https:\/\/doi.org\/10.1186\/s12944-019-1034-3 PMID: 30954084; PMCID: PMC6451778","journal-title":"Lipids Health Dis"},{"key":"185_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1476-511X-8-59","volume":"8","author":"EZ Jia","year":"2009","unstructured":"Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, Cao KJ, Huang J, Ma WZ, Yang ZJ, Zhang G (2009) Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis 8:59. https:\/\/doi.org\/10.1186\/1476-511X-8-59 PMID: 20030806; PMCID: PMC2808301","journal-title":"Lipids Health Dis"},{"issue":"1","key":"185_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0021-9150(98)00194-4","volume":"142","author":"A Laurila","year":"1999","unstructured":"Laurila A, Bloigu A, N\u00e4yh\u00e4 S, Hassi J, Leinonen M, Saikku P (1999) Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 142(1):207\u2013210. https:\/\/doi.org\/10.1016\/s0021-9150(98)00194-4 PMID: 9920523","journal-title":"Atherosclerosis."},{"key":"185_CR31","doi-asserted-by":"publisher","unstructured":"Niemel\u00e4 S, Karttunen T, Korhonen T, L\u00e4\u00e4r\u00e4 E, Karttunen R, Ik\u00e4heimo M, Kes\u00e4niemi YA. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart. 1996;75(6):573-5. doi: https:\/\/doi.org\/10.1136\/hrt.75.6.573. PMID: 8697159; PMCID: PMC484379.","DOI":"10.1136\/hrt.75.6.573"},{"key":"185_CR32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2147\/IJGM.S243848","volume":"13","author":"A Abdu","year":"2020","unstructured":"Abdu A, Cheneke W, Adem M, Belete R, Getachew A (2020) Dyslipidemia and associated factors among patients suspected to have Helicobacter pylori infection at Jimma University Medical Center, Jimma, Ethiopia. Int J Gen Med 13:311\u2013321. https:\/\/doi.org\/10.2147\/IJGM.S243848 PMID: 32606896; PMCID: PMC7306453","journal-title":"Int J Gen Med"},{"issue":"6","key":"185_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1523-5378.2002.00106.x","volume":"7","author":"E Serin","year":"2002","unstructured":"Serin E, G\u00fcm\u00fcrd\u00fcl\u00fc Y, Ozer B, Kayasel\u00e7uk F, Yilmaz U, Ko\u00e7ak R (2002) Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter. 7(6):337\u2013341. https:\/\/doi.org\/10.1046\/j.1523-5378.2002.00106.x PMID: 12485119","journal-title":"Helicobacter."},{"issue":"2","key":"185_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/BF02090202","volume":"39","author":"R Carmel","year":"1994","unstructured":"Carmel R, Perez-Perez GI, Blaser MJ (1994) Helicobacter pylori infection and food-cobalamin malabsorption. Dig Dis Sci 39(2):309\u2013314. https:\/\/doi.org\/10.1007\/BF02090202 PMID: 8313813","journal-title":"Dig Dis Sci"},{"issue":"1","key":"185_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1572-0241.2001.03453.x","volume":"96","author":"R Carmel","year":"2001","unstructured":"Carmel R, Aurangzeb I, Qian D (2001) Associations of food-cobalamin malabsorption with ethnic origin, age, Helicobacter pylori infection, and serum markers of gastritis. Am J Gastroenterol 96(1):63\u201370. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.03453.x PMID: 111972","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"185_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1055\/s-0037-1614438","volume":"81","author":"M Cattaneo","year":"1999","unstructured":"Cattaneo M (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81(2):165\u2013176 PMID: 10063987","journal-title":"Thromb Haemost"},{"issue":"4","key":"185_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1572-0241.2002.05601.x","volume":"97","author":"A Tamura","year":"2002","unstructured":"Tamura A, Fujioka T, Nasu M (2002) Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol 97(4):861\u2013866. https:\/\/doi.org\/10.1111\/j.1572-0241.2002.05601.x PMID: 12003420","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"185_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/hel.12188","volume":"20","author":"J Liu","year":"2015","unstructured":"Liu J, Wang F, Shi S (2015) Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants. Helicobacter. 20(3):176\u2013183. https:\/\/doi.org\/10.1111\/hel.12188 Epub 2014 Nov 8. PMID: 25382293","journal-title":"Helicobacter."},{"issue":"7218","key":"185_CR39","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/bmj.319.7218.1157","volume":"319","author":"J Danesh","year":"1999","unstructured":"Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R (1999) Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 319(7218):1157\u20131162. https:\/\/doi.org\/10.1136\/bmj.319.7218.1157 PMID: 10541503; PMCID: PMC28263","journal-title":"BMJ"},{"issue":"4","key":"185_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1574-695X.2000.tb01533.x","volume":"29","author":"AM Alkout","year":"2000","unstructured":"Alkout AM, Ramsay EJ, Mackenzie DA, Weir DM, Bentley AJ, Elton RA, Sutherland S, Busuttil A, Blackwell CC (2000) Quantitative assessment of IgG antibodies to Helicobacter pylori and outcome of ischaemic heart disease. FEMS Immunol Med Microbiol 29(4):271\u2013274. https:\/\/doi.org\/10.1111\/j.1574-695X.2000.tb01533.x PMID: 11118907","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"185_CR41","first-page":"341","volume":"16","author":"H Shmuely","year":"2014","unstructured":"Shmuely H, Wattad M, Solodky A, Yahav J, Samra Z, Zafrir N (2014) Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging. Isr Med Assoc J 16(6):341\u2013346 PMID: 25058994","journal-title":"Isr Med Assoc J"},{"issue":"2","key":"185_CR42","first-page":"112","volume":"125","author":"R Vijayvergiya","year":"2007","unstructured":"Vijayvergiya R (2007) Association of infection with coronary artery disease. Indian J Med Res 125(2):112\u2013114 PMID: 17431279","journal-title":"Indian J Med Res"},{"issue":"2","key":"185_CR43","first-page":"129","volume":"125","author":"P Goyal","year":"2007","unstructured":"Goyal P, Kalek SC, Chaudhry R, Chauhan S, Shah N (2007) Association of common chronic infections with coronary artery disease in patients without any conventional risk factors. Indian J Med Res 125(2):129\u2013136 PMID: 17431281","journal-title":"Indian J Med Res"},{"issue":"50","key":"185_CR44","doi-asserted-by":"publisher","first-page":"e18348","DOI":"10.1097\/MD.0000000000018348","volume":"98","author":"Y Fang","year":"2019","unstructured":"Fang Y, Fan C, Xie H (2019) Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: a systematic review and meta-analysis. Medicine 98(50):e18348. https:\/\/doi.org\/10.1097\/MD.0000000000018348 PMID: 31852134; PMCID: PMC6922357","journal-title":"Medicine"},{"issue":"4","key":"185_CR45","first-page":"138","volume":"7","author":"M Rogha","year":"2012","unstructured":"Rogha M, Dadkhah D, Pourmoghaddas Z, Shirneshan K, Nikvarz M, Pourmoghaddas M (2012) Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 7(4):138\u2013141 PMID: 23205045; PMCID: PMC3413081","journal-title":"ARYA Atheroscler"},{"issue":"7117","key":"185_CR46","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/bmj.315.7117.1199","volume":"315","author":"NJ Wald","year":"1997","unstructured":"Wald NJ, Law MR, Morris JK, Bagnall AM (1997) Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 315(7117):1199\u20131201. https:\/\/doi.org\/10.1136\/bmj.315.7117.1199 PMID: 9393222; PMCID: PMC2127748","journal-title":"BMJ"},{"issue":"5 Pt 2","key":"185_CR47","doi-asserted-by":"publisher","first-page":"S434","DOI":"10.1016\/s0002-8703(99)70270-x","volume":"138","author":"J Danesh","year":"1999","unstructured":"Danesh J (1999) Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 138(5 Pt 2):S434\u2013S437. https:\/\/doi.org\/10.1016\/s0002-8703(99)70270-x PMID: 10539843","journal-title":"Am Heart J"},{"issue":"3","key":"185_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1136\/heart.85.3.304","volume":"85","author":"F Schiele","year":"2001","unstructured":"Schiele F, Batur MK, Seronde MF, Meneveau N, Sewoke P, Bassignot A, Couetdic G, Caulfield F, Bassand JP (2001) Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study. Heart 85(3):304\u2013311 doi: 10.1136\/heart.85.3.304. PMID: 11179272; PMCID: PMC1729637","journal-title":"Heart"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-021-00185-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00185-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T09:14:57Z","timestamp":1625303697000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-021-00185-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s43044-021-00185-2","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,3]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that he has no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}